Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBT Margin (2020 - 2026)

PROCEPT BioRobotics has reported EBT Margin over the past 7 years, most recently at 38.11% for Q1 2026.

  • Quarterly EBT Margin fell 227.0% to 38.11% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 31.78% through Mar 2026, up 430.0% year-over-year, with the annual reading at 30.96% for FY2025, 959.0% up from the prior year.
  • EBT Margin was 38.11% for Q1 2026 at PROCEPT BioRobotics, up from 38.82% in the prior quarter.
  • Over five years, EBT Margin peaked at 24.73% in Q2 2025 and troughed at 121.05% in Q1 2022.
  • The 5-year median for EBT Margin is 58.28% (2024), against an average of 65.33%.
  • Year-over-year, EBT Margin skyrocketed 7620bps in 2022 and then crashed -1173bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 104.78% in 2022, then soared by 40bps to 62.93% in 2023, then skyrocketed by 57bps to 27.09% in 2024, then tumbled by -43bps to 38.82% in 2025, then increased by 2bps to 38.11% in 2026.
  • Per Business Quant, the three most recent readings for PRCT's EBT Margin are 38.11% (Q1 2026), 38.82% (Q4 2025), and 25.7% (Q3 2025).